
501 - 1000 funcionários
Fundada em 2014
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
Healthcare • Biotechnology • Pharmaceuticals
A Iovance Biotherapeutics, Inc. está revolucionando o tratamento do câncer ao aproveitar a capacidade do sistema imunológico humano de reconhecer e atacar células cancerígenas diversas em cada paciente. A empresa se concentra em imunoterapia baseada em células T, especificamente a terapia com Linfócitos T Infiltrantes de Tumor (TIL), que consiste em revigorar os TILs de um paciente para combater o câncer. A terapia TIL da Iovance está sendo investigada em ensaios clínicos para diversos tipos de câncer sólidos avançados. Além disso, a empresa está avançando em terapias TIL geneticamente modificadas e explorando aplicações potenciais da terapia PBL (linfócitos do sangue periférico) para cânceres hematológicos. Como líder em terapia celular, a Iovance possui um moderno Centro de Terapia Celular na Filadélfia para fabricar suas terapias utilizando GMP proprietária. A empresa está na vanguarda do desenvolvimento de tratamentos contra o câncer personalizados e específicos para cada paciente.
🕒 Junho 16
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

501 - 1000 funcionários
Fundada em 2014
🏥 Saúde
🧬 Biotecnologia
💊 Farmacêutico
Healthcare • Biotechnology • Pharmaceuticals
A Iovance Biotherapeutics, Inc. está revolucionando o tratamento do câncer ao aproveitar a capacidade do sistema imunológico humano de reconhecer e atacar células cancerígenas diversas em cada paciente. A empresa se concentra em imunoterapia baseada em células T, especificamente a terapia com Linfócitos T Infiltrantes de Tumor (TIL), que consiste em revigorar os TILs de um paciente para combater o câncer. A terapia TIL da Iovance está sendo investigada em ensaios clínicos para diversos tipos de câncer sólidos avançados. Além disso, a empresa está avançando em terapias TIL geneticamente modificadas e explorando aplicações potenciais da terapia PBL (linfócitos do sangue periférico) para cânceres hematológicos. Como líder em terapia celular, a Iovance possui um moderno Centro de Terapia Celular na Filadélfia para fabricar suas terapias utilizando GMP proprietária. A empresa está na vanguarda do desenvolvimento de tratamentos contra o câncer personalizados e específicos para cada paciente.
• The LCL is responsible for shaping the program's cross-functional vision, strategic context, and lifecycle plan (LCP) for both current and future business opportunities. • The LCL, in partnership with the Program Manager, will work with leadership & SMEs (subject matter experts) to build out appropriate internal ways of working to enable best practices around development of data driven recommendations, decision making and communication. • As the single point of accountability in a cross-functional team, the LCL ensures timely delivery and manages the associated execution plan and milestones, closely aligning them with the approved LCP. • The LCL oversees integration across Iovance involving multiple stakeholders to ensure optimal program execution in line with program strategy and LCP. • Collaborating with functional team leaders, the LCL fosters alignment across the different sub -teams to ensure execution will achieve team and corporate goals (Commercial Team, Development Team, Regulatory Team etc.) • Serving as a point of triage, the LCL facilitates clear decision-making by incorporating cross-functional input to address high-impact issues. This involves co-creating solutions to complex challenges in real time. • The LCL leads the team in framing program needs and develops a range of options and recommendations for presentation to the Executive Leadership Team (ELT). The LCL ensures transparent communication with senior leadership, highlighting relevant scenarios, assumptions, and risks to inform decision-making and trade-offs. The LCL also represents the enterprise mindset and ensures all relevant functional perspectives have been considered. • The LCL ensures the inclusion of subject matter experts (SMEs) and situational members in discussions, guided by a predefined agenda set with guidance from the Program Manager. • The LCL is accountable to the ELT for program recommendations and frames them within the context of the broader portfolio. • The LCL is accountable for day-to-day management of the program to ensure all established deliverables with high program impact remain on track and in line with program strategy. • The LCL is responsible for ensuring the health of the team, creating a highly functional environment with collaborative ways of working where debate and honest feedback are encouraged • Other responsibilities to consider: Risk identification and mitigation planning; ensuring financial stewardship of approved and recommended projects; clear communication throughout organization of key milestones, deliverables and progress; ensure appropriate resourcing of functions to achieve program goals and vision.
• Bachelor's degree in a scientific discipline; advanced or professional degree highly desirable (e.g., PhD, MD, or MBA). • 15+ years of bio-pharmaceutical industry experience with at least 5 years of relevant work experiences in the biotech/pharmaceutical industry as a Lifecycle Leader or Program Team Leader. • Must demonstrate strong knowledge of the overall drug development process relevant to biotech/ pharmaceutical companies; commercial launch experience and a depth of experience with drug development is required. • Experience working with or on program strategy teams required.
• Iovance is committed to cultivating and offering a diverse and inclusive work environment. • Equal-opportunity employer. • Reasonable accommodations may be made upon request to enable individuals to perform essential functions.
Candidatar-se🕒 Junho 16
Director of Portfolio Asset Management overseeing multifamily loan portfolios at The Community Preservation Corporation. Leading a team and ensuring risk management in affordable housing finance.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 16
Associate Director, Client Media Solutions overseeing media activation campaigns. Leading strategy and management for healthcare clients at Real Chemistry.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $85.000 - $105.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 16
Director overseeing global category strategy for power infrastructure at Vantage Data Centers. Leading sourcing, supplier management, and execution for high-scale energy projects.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $250.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 16
Director of Support Intelligence & Transformation at Everbridge, enhancing operational intelligence and AI-driven workflows. Leading transformation initiatives for proactive customer operations in critical communications.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $174.000 - $220.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 16
Lead strategic initiatives for data integration and client data solutions at Cielo. Ensure high-quality data products and collaborate across technical and business teams.
🗣️🇺🇸🇬🇧 Inglês obrigatório